Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Head and Neck Pathology
Published in: Head and Neck Pathology 1/2017

01-03-2017 | Original Paper

Update from the 4th Edition of the World Health Organization of Head and Neck Tumours: Tumours of the Oral Cavity and Mobile Tongue

Author: Susan Müller

Published in: Head and Neck Pathology | Issue 1/2017

Login to get access

Abstract

There have been several additions and deletions in Chapter 4 on Tumours of the oral cavity and mobile tongue in the 2017 fourth edition of the World Health Organization Classification of Tumours of the Head and Neck. This chapter excludes the oropharynx, which now is a stand-alone chapter acknowledging the uniqueness of the oropharynx from the oral cavity. New entries in Chapter 4 include rhabdomyoma, haemangioma, schwannoma, neurofibroma and myofibroblastic sarcoma in the section titled Soft tissue and neural tumours. Discussion of salivary gland entities have been reduced and includes mucoepidermoid carcinoma and pleomorphic adenoma as the other salivary gland types are discussed elsewhere. In the Haematolymphoid tumours section, like the salivary gland section, only tumors that commonly present in the oral cavity are discussed in Chapter 4. Excluded entities in the updated classification include papillary hyperplasia, median rhomboid glossitis, keratoacanthoma, focal oral mucinosis, and secondary tumors. This article will summarize the changes in the new classification since the 2005 edition focusing on selected entities that have had significant changes along with new entries.
Literature
1.
Tumours of the oral cavity and mobile tongue. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors, WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
2.
Sloan P, Gale N, Hunter K, et al. Malignant surface epithelial tumours: Squamous cell carcinoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press, 2017.
3.
Dahlgren L, Dahlstrand HM, Lindquist D, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004;112:1015–9.CrossRefPubMed
4.
Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235–42.CrossRefPubMedPubMedCentral
5.
Lingen MW, Xiao W, Schmitt A, et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013;49:1–8.CrossRefPubMed
6.
Sgaramella N, Coates PJ, Strindlund K, et al. Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1. Br J Cancer. 2015;113:321–6.CrossRefPubMedPubMedCentral
7.
Zafereo ME, Xu L, Dahlstrom KR, Viamonte CA, et al. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol. 2016;56:47–53.CrossRefPubMed
8.
Reuschenbach M, Kansy K, Garbe K, et al. Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany. Oral Oncol. 2013;49(9):937–42.CrossRefPubMed
9.
Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112:580–93.CrossRefPubMed
10.
Goldstein BY, Chang SC, Hashibe M, et al. Alcohol consumption and cancers of the oral cavity and pharynx from 1988 to 2009: an update. Eur J Cancer Prev. 2010;19:431–65.CrossRefPubMedPubMedCentral
11.
IARC. (2010). Alcohol consumption and ethyl carbamate. IARC Monogr Eval Carcinog Risks Hum. 96:1–1428.
12.
Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people–a comprehensive literature review. Oral Oncol. 2001;37:401–18.CrossRefPubMed
13.
Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer. 2005;103:1843–9.CrossRefPubMed
14.
15.
Fritsch VA, Gerry DR, Lentsch EJ. Basaloid squamous cell carcinoma of the oral cavity: an analysis of 92 cases. Laryngoscope. 2014;124:1573–8.CrossRefPubMed
16.
Bice TC, Tran V, Merkley MA, et al. Disease-Specific survival with spindle cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2015;153:973–80.CrossRefPubMed
17.
Kass JI, Lee SC, Abberbock S, et al. Adenosquamous carcinoma of the head and neck: Molecular analysis using CRTC-MAML FISH and survival comparison with paired conventional squamous cell carcinoma. Laryngoscope. 2015;125:E371–E6.CrossRefPubMed
18.
Sun Y, Kuyama K, Burkhardt A, Yamamoto H. Clinicopathological evaluation of carcinoma cuniculatum: a variant of oral squamous cell carcinoma. J Oral Pathol Med. 2012;41:303–8.CrossRefPubMed
19.
Mallick S, Breta M, Gupta SD, et al. Angiogenesis, proliferative activity and DNA ploidy in oral verrucous carcinoma: a comparative study including verrucous hyperplasia and squamous cell carcinoma. Pathol Oncol Res. 2015;21:1249–57.CrossRefPubMed
20.
Samman M, Wood HM, Conway C, et al. A novel genomic signature reclassifies an oral cancer subtype. Int J Cancer. 2015;137:2364–73.CrossRefPubMed
21.
Garcia C, Crowson AN. Acantholytic squamous cell carcinoma: is it really a more aggressive tumor? Dermatol Surg. 2011;37:353–6.CrossRefPubMed
22.
Rytkönen AE, Hirvikoski PP, Salo TA. Lymphoepithelial carcinoma: two case reports and a systematic review of oral and sinonasal cases. Head Neck Pathol. 2011;5:327–34.CrossRefPubMedPubMedCentral
23.
Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29:167–78.CrossRefPubMed
24.
Li Y, Bai S, Carroll W, Dayan D, et al. Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head Neck Pathol. 2013;7:211–23.CrossRefPubMed
25.
Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006;42:229–39.
26.
Woolgar JA, Triantafyllou A. Squamous cell carcinoma and precursor lesions: clinical pathology. Periodontol 2000. 2011;57:51–72.CrossRef
27.
Almangush A, Bello IO, Coletta RD, et al. For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch. 2015;467:39–46.CrossRefPubMed
28.
Ridge JA, Lydiatt WM, Patel SG, et al. Head and Neck In: Amin MB, Edge S, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC cancer staging manual. 8th ed. New York: Springer; 2017:79–94.CrossRef
29.
Reibel J, Gale N, Hille J, et al. Oral potentially malignant disorders and oral epithelial dysplasia. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors, WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
30.
Kuribayashi Y, Tsushima F, Morita K, et al. Long-term outcome of non-surgical treatment in patients with oral leukoplakia. Oral Oncol. 2015;51:1020–5.CrossRefPubMed
31.
Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770–80.CrossRefPubMed
32.
Gale N, Blagus R, El-Mofty SK, et al. Evaluation of a new grading system for laryngeal squamous intraepithelial lesions—a proposed unified classification. Histopathology. 2014;65:456–64.CrossRefPubMed
33.
Woo SB, Cashman EC, Lerman MA. Human papillomavirus-associated oral intraepithelial neoplasia. Mod Pathol. 2013;26:1288–97.CrossRefPubMed
34.
Vigneswaran N, Carlos R, Lippman S, et al. Multifocal epithelial hyperplasia. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, edotors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
35.
Carlos R, Sedano HO. Multifocal papilloma virus epithelial hyperplasia. Oral Surg Oral Med Oral Pathol. 1994;77:631–5.CrossRefPubMed
36.
King MD, Reznik DA, O’Daniels CM, et al. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis. 2002;34:641–8.CrossRefPubMed
37.
Said AK, Leao JC, Fedele S, Porter SR. Focal epithelial hyperplasia—an update. J Oral Pathol Med. 2013;42:435–42.CrossRefPubMed
38.
Archard HO, Heck JW, Stanley HR. Focal epithelial hyperplasia: an unusual oral mucosal lesion found in Indian children. Oral Surg Oral Med Oral Pathol. 1965;20:201–12.CrossRefPubMed
39.
Henke RP, Guèrin-Reverchon I, Milde-Langosch K, et al. In situ detection of human papillomavirus types 13 and 32 in focal epithelial hyperplasia of the oral mucosa. J Oral Pathol Med. 1989;18:419–21.CrossRefPubMed
40.
Bishop J, Gnepp DR, Ro JY. Ectomesenchymal chondromyxoid tumour. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
41.
Aldojain A, Jaradat J, Summersgill K, Bilodeau EA. Ectomesenchymal chondromyxoid tumor: a series of seven cases and review of the literature. Head Neck Pathol. 2015;9:315–22.CrossRefPubMed
42.
Nigam S, Dhingra KK, Gulati A. Ectomesenchymal chondromyxoid tumor of the hard palate–a case report. J Oral Pathol Med. 2006;35:126–8.CrossRefPubMed
43.
Goveas N, Ethunandan M, Cowlishaw D, Flood TR. Ectomesenchymal chondromyxoid tumour of the tongue: unlikely to originate from myoepithelial cells. Oral Oncol. 2006;42:1026–8.CrossRefPubMed
44.
Smith BC, Ellis GL, Meis-Kindblom JM, Williams SB. Ectomesenchymal chondromyxoid tumor of the anterior tongue. Nineteen cases of a new clinicopathologic entity. Am J Surg Pathol. 1995;19:519–30.CrossRefPubMed
45.
Bullerdiek J, Ro JY. Thompson LDR. rhabdomyoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
46.
Hettmer S, Teot LA, van Hummelen P, et al. Mutations in Hedgehog pathway genes in fetal rhabdomyomas. J Pathol. 2013;231:44–52.CrossRefPubMed
47.
Bullerdiek J, Flucke U. Lymphangioma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
48.
Kardon DE, Wenig BM, Heffner DK, Thompson LD. Tonsillar lymphangiomatous polyps: a clinicopathologic series of 26 cases. Mod Pathol. 2000;13:1128–33.CrossRefPubMed
49.
Bruder E, Alaggio R, Kozakewich HP, et al. Vascular and perivascular lesions of skin and soft tissues in children and adolescents. Pediatr Dev Pathol. 2012;15:26–61.
50.
51.
Mardekian S, Karp JK. Lymphangioma of the palatine tonsil. Arch Pathol Lab Med. 2013;137:1837–42.CrossRefPubMed
52.
Rekhi B, Sethi S, Kulkarni SS, Jambhekar NA. Kaposiform hemangioendothelioma in tonsil of a child associated with cervical lymphangioma: a rare case report. World J Surg Oncol. 2011;9:57.CrossRefPubMedPubMedCentral
53.
54.
Bullerdiek J, Flucke U. Haemangioma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
55.
Açikgöz A, Sakallioglu U, Ozdamar S, Uysal A. Rare benign tumours of oral cavity–capillary haemangioma of palatal mucosa: a case report. Int J Paediatr Dent. 2000;10:161–5.PubMed
56.
Bonet-Coloma C, Mínguez-Martínez I, Palma-Carrió C, et al. Clinical characteristics, treatment and outcome of 28 oral haemangiomas in pediatric patients. Med Oral Patol Oral Cir Bucal. 2011;16:e19–e22.CrossRefPubMed
57.
Maaita JK. Oral tumors in child- ren: a review. J Clin Pediatr Dent. 2000;24:133–5.PubMed
58.
Sato M, Tanaka N, Sato T, Amagasa T. Oral and maxillofacial tumours in children: a review. Br J Oral Maxillofac Surg. 1997;35:92–5.CrossRefPubMed
59.
Flucke U, Franchi A. Myofibroblastic sarcoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
60.
Fisher C. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas. Ultrastruct Pathol. 2003;428:291–305.
61.
Mentzel T, Dry S, Katenkamp D, Fletcher CD. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol. 1998;22:1228–38.CrossRefPubMed
62.
Inagaki H, Bell D, Brandwein-Gensler M. Mucoepidermoid Carcinoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
63.
Bell D, Brandwein-Gensler M, Chiosea S. Pleomorphic Adenoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
64.
Feldman AL, Boy S, Ferry JA, et al. CD30-positive T-cell lymphoproliferative disorder. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press, 2017.
65.
Rosenberg A, Biesma DH, Sie-Go DM, Slootweg PJ. Primary extranodal CD30-positive T-cell non-Hodgkins lymphoma of the oral mucosa. Report of two cases. Int J Oral Maxillofac Surg. 1996;25:57–9.CrossRefPubMed
66.
Sciallis AP, Law ME, Inwards DJ, et al. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol. 2012;25:983–92.CrossRefPubMed
67.
Wang W, Cai Y, Sheng W, Lu H, Li X. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:96–104.CrossRefPubMed
68.
Alobeid B, Pan LX, Milligan L, et al. Eosinophil-rich CD30+ lymphoproliferative disorder of the oral mucosa. A form of “traumatic eosinophilic granuloma”. Am J Clin Pathol. 2004;121:43–50.CrossRefPubMed
69.
Hirshberg A, Amariglio N, Akrish S, et al. Traumatic ulcerative granuloma with stromal eosinophilia: a reactive lesion of the oral mucosa. Am J Clin Pathol. 2006;126:522–9.CrossRefPubMed
70.
Boy S, Ferry JA. Plasmablastic lymphoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press, 2017.
71.
Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015;125:2323–30.CrossRefPubMed
72.
Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83:804–9.CrossRefPubMed
73.
Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413–20.PubMed
74.
Boy S, van Heerden M, Pool R, et al. Plasmablastic lymphoma versus diffuse large B-cell lymphoma with plasmablastic differentiation: proposal for a novel diagnostic scoring system. J Hematop. 2015;8:3–11.CrossRef
75.
Loghavi S, Alayed K, Aladily TN, et al. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol. 2015;8:65.CrossRefPubMedPubMedCentral
Metadata
Title
Update from the 4th Edition of the World Health Organization of Head and Neck Tumours: Tumours of the Oral Cavity and Mobile Tongue
Author
Susan Müller
Publication date
01-03-2017
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2017
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-017-0792-3

Other articles of this Issue 1/2017

Head and Neck Pathology 1/2017 Go to the issue

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What Is New in the 2017 WHO Blue Book for Tumors and Tumor-Like Lesions of the Neck and Lymph Nodes

Original Paper

Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Oropharynx